07/18/2019 | Press release | Distributed by Public on 07/18/2019 15:36
SANTA BARBARA, Calif., July 18, 2019 (GLOBE NEWSWIRE) -- Sientra, Inc. (Nasdaq: SIEN), a medical aesthetics company, announced today that it will release financial results for the second quarter 2019 after the close of trading on Thursday, August 8, 2019. Sientra will host a conference call to discuss financial results the same day at 4:30 p.m. Eastern Time.
The dial-in numbers are 844-464-3933 for domestic callers and 765-507-2612 for international callers. The conference ID is 8084147. A live webcast of the conference call will be available on the Investor Relations section of the Company's website at www.sientra.com.
A replay of the call will be available starting on August 8, 2019 at 7:30 p.m. Eastern Time through August 15, 2019 at 7:30 p.m. Eastern Time. To access the replay, dial 855-859-2056 for domestic callers and 404-537-3406 for international callers and use the replay conference ID 8084147. A replay of the webcast will be available on the Investor Relations section of the Company's website following the completion of the call.
Headquartered in Santa Barbara, California, Sientra is a diversified global medical aesthetics company and a leading partner to aesthetic physicians. The Company offers a suite of products designed to make a difference in patients' lives by enhancing their body image, growing their self-esteem, and restoring their confidence. Sientra has developed a broad portfolio of products with technologically differentiated characteristics, supported by independent laboratory testing and strong clinical trial outcomes. The Company's Breast Products Segment includes its OPUS™ breast implants, the first fifth generation breast implants approved by the FDA for sale in the United States, its ground-breaking Allox2® breast tissue expander with patented dual-port and integral drain technology, and BIOCORNEUM® the #1 performing, preferred and recommended scar gel of plastic surgeons(*). The Company's miraDry Segment comprises its miraDry® system, which is approved for sale in over 40 international markets, and is the only non-invasive FDA-cleared device for the permanent reduction of underarm sweat, odor and hair of all colors.
(*) Data on file
Investor Relations 805-679-8885
Source: Sientra, Inc.